News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

APT Pharmaceutical LLC Adds Vivo Ventures In Final Close Of $9 Million First Round


3/21/2006 1:52:46 PM

TUCSON, Ariz.--(BUSINESS WIRE)--March 21, 2006--Vivo Ventures participated in the final close of a $9 million Series A financing co-led by Charter Life Sciences and Research Corporation Technologies. APT Pharmaceuticals is a clinical-stage biopharmaceutical company developing products to treat asthma, chronic pulmonary obstructive disease, rhinitis and rhinovirus infection.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES